Concepedia

Penglu Wang

PW

Statistics

Publications

1

Citations

14

H-Index

1

Active since

2023

Affiliations

National Center for Drug Screening(Current)

Penglu Wang is an author at National Center for Drug Screening specializing in signal transduction, nuclear factor kappa b inhibition, and immunology.

Publications per year

2023–2023

1

Publications

1

Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway

Lu Yang, Tingting Zhang, Penglu Wang et al. · Cell Biology and Toxicology · 2023 · 14 citations

Life Sciences, Immunology, Molecular Biology +14

1–1 of 1